| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 251,8 k € | +33.8% | 188,1 k € | -33.0% | 280,7 k € | -8.4% | 306,4 k € | +59.5% | 192,1 k € | +4.1% | 184,4 k € | -21.4% | 234,7 k € | +17.1% | 200,4 k € | -53.9% | 435,0 k € | +22.3% | 355,7 k € | +4.5% | 340,5 k € | +0.1% | 340,2 k € | +10.2% | 308,9 k € | +4.1% | 296,7 k € | +7.3% | 276,4 k € | +17.6% | 235,1 k € | -3.9% | 244,7 k € | +1.6% | 240,8 k € | +31.4% | 183,3 k € | |
| EBITDA | 117,8 k € | +78.4% | 66,0 k € | -63.4% | 180,2 k € | -8.0% | 195,8 k € | +241.5% | 57,3 k € | -32.9% | 85,4 k € | -33.4% | 128,2 k € | +16.0% | 110,5 k € | -68.6% | 352,4 k € | +15.5% | 305,0 k € | +1.4% | 300,7 k € | -0.3% | 301,6 k € | +16.0% | 260,0 k € | +48.2% | 175,4 k € | -0.6% | 176,4 k € | +15.0% | 153,5 k € | -7.5% | 166,0 k € | -1.9% | 169,2 k € | +50.4% | 112,5 k € | |
| Operating profit | 80,2 k € | +57.4% | 50,9 k € | -69.8% | 168,9 k € | -8.6% | 184,9 k € | +296.6% | 46,6 k € | -37.8% | 74,9 k € | -30.8% | 108,2 k € | +19.5% | 90,5 k € | -72.7% | 332,2 k € | +16.6% | 285,0 k € | +11.8% | 254,9 k € | -12.0% | 289,7 k € | +17.2% | 247,2 k € | +54.0% | 160,5 k € | +3.3% | 155,4 k € | +18.6% | 131,1 k € | -14.2% | 152,7 k € | +2.2% | 149,5 k € | +54.3% | 96,9 k € | |
| Profit/loss | 110,8 k € | +77.3% | 62,5 k € | -62.0% | 164,6 k € | +5.0% | 156,8 k € | +710.8% | 19,3 k € | -71.5% | 67,9 k € | +9.1% | 62,3 k € | -54.2% | 136,1 k € | -45.3% | 249,0 k € | +24.4% | 200,1 k € | -1.1% | 202,3 k € | -4.7% | 212,3 k € | +10.4% | 192,3 k € | +27.7% | 150,6 k € | +11.5% | 135,0 k € | +21.3% | 111,3 k € | -16.3% | 133,0 k € | +3.1% | 129,0 k € | +40.1% | 92,1 k € | |
| Equity | 3,5 M € | +2.7% | 3,4 M € | +1.9% | 3,3 M € | +3.2% | 3,2 M € | +5.1% | 3,1 M € | +0.6% | 3,1 M € | +2.3% | 3,0 M € | +2.1% | 2,9 M € | +4.9% | 2,8 M € | +8.7% | 2,6 M € | +8.3% | 2,4 M € | +9.3% | 2,2 M € | +10.7% | 2,0 M € | +10.9% | 1,8 M € | +9.1% | 1,6 M € | +6.8% | 1,5 M € | +7.7% | 1,4 M € | +10.4% | 1,3 M € | +11.2% | 1,1 M € | |
| Total assets | 4,1 M € | +11.2% | 3,7 M € | +2.3% | 3,6 M € | +4.6% | 3,4 M € | +2.6% | 3,4 M € | -0.2% | 3,4 M € | +2.0% | 3,3 M € | -0.5% | 3,3 M € | +1.5% | 3,3 M € | +9.2% | 3,0 M € | +9.2% | 2,7 M € | +21.3% | 2,3 M € | +10.0% | 2,1 M € | +11.8% | 1,8 M € | +7.2% | 1,7 M € | +4.0% | 1,6 M € | +8.1% | 1,5 M € | +10.1% | 1,4 M € | -7.3% | 1,5 M € | |
| Cash | 112,3 k € | -26.2% | 152,2 k € | -34.0% | 230,6 k € | +7.3% | 214,9 k € | -40.0% | 358,2 k € | -69.5% | 1,2 M € | -5.3% | 1,2 M € | -13.1% | 1,4 M € | +17.7% | 1,2 M € | +4.7% | 1,2 M € | +53.7% | 753,6 k € | -44.2% | 1,3 M € | +18.4% | 1,1 M € | +29.0% | 883,6 k € | +15.1% | 768,0 k € | +10.8% | 693,4 k € | +22.9% | 564,0 k € | +23.0% | 458,5 k € | -21.5% | 583,8 k € | |
| Debts | 600,4 k € | +114.5% | 279,9 k € | +8.0% | 259,3 k € | +26.6% | 204,8 k € | -25.2% | 273,6 k € | -8.8% | 299,9 k € | -1.1% | 303,3 k € | -20.3% | 380,5 k € | -18.4% | 466,2 k € | +12.0% | 416,2 k € | +16.6% | 356,8 k € | +346.4% | 79,9 k € | -0.4% | 80,2 k € | +25.7% | 63,9 k € | -27.5% | 88,0 k € | -25.4% | 118,1 k € | +15.3% | 102,4 k € | +12.3% | 91,1 k € | -71.5% | 320,2 k € | |
| Staff | 2,6 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | — | 1,3 | 1 | 1 | 1,1 | 2 | 2 | 2 | 2 | 2,3 | 2,3 | |||||||||||||||||||
Private company with limited liability · Torhout · incorporated on 03/02/1986 · 2,6 ETP
Private company with limited liability profitable and well capitalised. Cash position declining (-26.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK DEVRIESE is a Private company with limited liability incorporated in 1986. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Torhout. It employs on average 2,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette